It anticipates using the funds to complete the development of its first set of diagnostic products, and for a set of clinical studies to obtain regulatory clearance.
The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.
Lifted by a strong flu season, Cobas Liat PCR placements reached 1,500 systems in the US. Globally, year-over-year sales for the point-of-care system grew 262 percent.
The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.
The Associated Press reports that researchers are applying gene-editing approaches to HIV treatment.
The researchers noted that this is the first time CRISPR was used to mutate a restriction factor in order to confer innate antiviral function to human cells.
With WHO prequalification, global health organizations can consider the Aptima HIV-1 Quant Dx for public-sector procurement in resource-limited countries.
In PLOS this week: genomic features of Leishmania donovani strains, population genetics of the parasitic nematode worm Thelazia callipaeda, and more.
In Nature this week: genome of ancient Alaskan infant, and more.
An Emory University team has sequenced the genome of the sooty mangabey, comparing the DNA to other primates including humans to further research in AIDS resistance
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.